| Randall Charles Blake, MD | |
|
1329 Lusitana St, Suite 602, Honolulu, HI 96813-2429 | |
| (808) 522-5055 | |
| (808) 524-6306 |
| Full Name | Randall Charles Blake |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 45 Years |
| Location | 1329 Lusitana St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447226055 | NPI | - | NPPES |
| 100171930A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 14192 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hilo Medical Center | Hilo, HI | Hospital |
| The Queens Medical Center | Honolulu, HI | Hospital |
| North Hawaii Community Hospital | Kamuela, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Island Urology Oahu Llc | 1951553551 | 2 |
News Archive
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Many people are sleep restricted, either because they have to or because they choose to be, she says. "Instead of going to bed when they are tired, like they should, people watch TV and want to have an active social life," she says. "People count on catching up on their sleep on the weekends, but it may not be enough."
Schizophrenia and bipolar disorder affect 3% to 4% of the world's population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and depression that can last from days to months. These symptoms usually begin in late adolescence, but can begin in early childhood or as late as a person's 40s or 50s. There is a strong genetic component related to bipolar disorder.
› Verified 5 days ago
| Entity Name | Island Urology Oahu Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235481185 PECOS PAC ID: 1951553551 Enrollment ID: O20121205000533 |
News Archive
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Many people are sleep restricted, either because they have to or because they choose to be, she says. "Instead of going to bed when they are tired, like they should, people watch TV and want to have an active social life," she says. "People count on catching up on their sleep on the weekends, but it may not be enough."
Schizophrenia and bipolar disorder affect 3% to 4% of the world's population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and depression that can last from days to months. These symptoms usually begin in late adolescence, but can begin in early childhood or as late as a person's 40s or 50s. There is a strong genetic component related to bipolar disorder.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall Charles Blake, MD 1329 Lusitana St, Suite 602, Honolulu, HI 96813-2429 Ph: (808) 522-5055 | Randall Charles Blake, MD 1329 Lusitana St, Suite 602, Honolulu, HI 96813-2429 Ph: (808) 522-5055 |
News Archive
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Many people are sleep restricted, either because they have to or because they choose to be, she says. "Instead of going to bed when they are tired, like they should, people watch TV and want to have an active social life," she says. "People count on catching up on their sleep on the weekends, but it may not be enough."
Schizophrenia and bipolar disorder affect 3% to 4% of the world's population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and depression that can last from days to months. These symptoms usually begin in late adolescence, but can begin in early childhood or as late as a person's 40s or 50s. There is a strong genetic component related to bipolar disorder.
› Verified 5 days ago
Dr. David Shu- An Chou, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1029 Kapahulu Ave, Suite 306, Honolulu, HI 96816 Phone: 808-218-7858 Fax: 808-218-7859 | |
Joseph Sterbis, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Urology Clinic, Honolulu, HI 96822 Phone: 808-433-2972 | |
Dr. Kent K. Teruya, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St Ste 508, Honolulu, HI 96813 Phone: 808-531-1511 | |
Sergei Tikhonenkov, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 | |
Ann M Aspera, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
William Joseph Yarbrough Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 Fax: 808-524-6306 | |
Dr. David C. Wei, MD, FACS Urology Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 Fax: 808-432-8241 |